Brian Elsbernd, Chief Compliance/Legal Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 17,212 shares at $21.65 ($372K) on 2024-11-26, disclosed to the SEC on 2024-11-29.
Open-market sale of $372k CPRX by Chief Compliance/Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.58 | 3,956 | $85K | 22.9% |
| 2 | $21.58 | 3,956 | $85K | 22.9% |
| 3 | $21.65 | 9,300 | $201K | 54.1% |
| Total | $21.62 avg | 17,212 | $372K | 100% |
| Filing → |
| CPRX | SELL | 2025-09-05 | $1.4M | — | Filing → |
| CPRX | SELL | 2025-03-05 | $2.9M | — | Filing → |
| CPRX | SELL | 2024-03-28 | $822K | — | Filing → |